000 | 01690 a2200517 4500 | ||
---|---|---|---|
005 | 20250513210227.0 | ||
264 | 0 | _c20000523 | |
008 | 200005s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCasoli, C | |
245 | 0 | 0 |
_aHTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. _h[electronic resource] |
260 |
_bBlood _cMay 2000 |
||
300 |
_a2760-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aChemokine CCL3 |
650 | 0 | 4 | _aChemokine CCL4 |
650 | 0 | 4 |
_aCytokines _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 |
_aHTLV-II Infections _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aLymphocytes _xdrug effects |
650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xbiosynthesis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProviruses _xisolation & purification |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aViral Load |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
700 | 1 | _aVicenzi, E | |
700 | 1 | _aCimarelli, A | |
700 | 1 | _aMagnani, G | |
700 | 1 | _aCiancianaini, P | |
700 | 1 | _aCattaneo, E | |
700 | 1 | _aDall'Aglio, P | |
700 | 1 | _aPoli, G | |
700 | 1 | _aBertazzoni, U | |
773 | 0 |
_tBlood _gvol. 95 _gno. 9 _gp. 2760-9 |
|
999 |
_c10732386 _d10732386 |